VYZULTA SIDE EFFECTS
- Generic Name: latanoprostene bunod ophthalmic solution
- Brand Name: Vyzulta
SIDE EFFECTS
The following adverse reactions are described elsewhere in the labeling:
- Pigmentation
- Eyelash Changes
- Intraocular Inflammation
- Macular Edema
- Bacterial Keratitis
- Use with Contact Lens
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
VYZULTA was evaluated in 811 patients in 2 controlled clinical trials of up to 12 months duration. The most common ocular adverse reactions observed in patients treated with latanoprostene bunod were: conjunctival hyperemia (6%), eye irritation (4%), eye pain (3%), and instillation site pain (2%). Approximately 0.6% of patients discontinued therapy due to ocular adverse reactions including ocular hyperemia, conjunctival irritation, eye irritation, eye pain, conjunctival edema, vision blurred, punctate keratitis and foreign body sensation.
SRC: NLM .